Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Brian J. Caveney net worth and biography

Brian Caveney Biography and Net Worth

EVP of Laboratory Co. of America

Dr Caveney holds an MD from the West Virginia University School of Medicine, a JD from the West Virginia University College of Law and an MPH in health policy and administration from the University of North Carolina at Chapel Hill. He completed his residency at Duke University Medical Center and is board-certified in preventive medicine, with a specialty in occupational and environmental medicine. He is the past president of the Southeastern Atlantic College of Occupational and Environmental Medicine and continues to hold an active law license in North Carolina.

Dr Caveney came to Labcorp after serving as chief medical officer of Blue Cross and Blue Shield of North Carolina (Blue Cross NC) since 2011. Dr Caveney also served as chief clinical officer of Mosaic Health Solutions, a wholly owned subsidiary of Blue Cross NC for strategic investments in diversified health solutions businesses. Prior to joining Blue Cross NC, Dr Caveney was a practicing physician and assistant professor at Duke University Medical Center and also provided consulting services for several companies in the Research Triangle Park region.

At Labcorp, Dr Caveney has broad responsibility for medical and scientific strategy, including serving as primary medical representative for the company externally, defining global standards for medical and scientific activities across Labcorp’s Diagnostics and Drug Development businesses, and enhancing a culture of medical and scientific excellence.

What is Brian J. Caveney's net worth?: The estimated net worth of Brian J. Caveney is at least $2.97 million as of September 7th, 2022. Dr. Caveney owns 14,282 shares of Laboratory Co. of America stock worth more than $2,969,799 as of April 25th. This net worth approximation does not reflect any other assets that Dr. Caveney may own. Learn More about Brian J. Caveney's net worth.
How do I contact Brian J. Caveney?: The corporate mailing address for Dr. Caveney and other Laboratory Co. of America executives is 358 South Main Street, BURLINGTON NC, 27215. Laboratory Co. of America can also be reached via phone at (336) 229-1127 and via email at [email protected]. Learn More on Brian J. Caveney's contact information.
Has Brian J. Caveney been buying or selling shares of Laboratory Co. of America?: Brian J. Caveney has not been actively trading shares of Laboratory Co. of America over the course of the past ninety days. Most recently, on Wednesday, September 7th, Brian J. Caveney bought 44 shares of Laboratory Co. of America stock. The stock was acquired at an average cost of $231.20 per share, with a total value of $10,172.80. Following the completion of the transaction, the executive vice president now directly owns 14,282 shares of the company's stock, valued at $3,301,998.40. Learn More on Brian J. Caveney's trading history.
Who are Laboratory Co. of America's active insiders?: Laboratory Co. of America's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Brian Caveney (EVP), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Laboratory Co. of America's active insiders.
Are insiders buying or selling shares of Laboratory Co. of America?: During the last year, insiders at the medical research company sold shares 14 times. They sold a total of 66,701 shares worth more than $14,419,280.01. The most recent insider tranaction occured on April, 1st when COO Mark S Schroeder sold 6,477 shares worth more than $1,407,387.33. Insiders at Laboratory Co. of America own 0.9% of the company. Learn More about insider trades at Laboratory Co. of America.
Information on this page was last updated on 4/1/2024.

Brian J. Caveney Insider Trading History at Laboratory Co. of America

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/7/2022	Buy	44	$231.20	$10,172.80	14,282
6/7/2022	Buy	42	$242.19	$10,171.98	14,172

Brian J. Caveney Buying and Selling Activity at Laboratory Co. of America

Laboratory Co. of America Company Overview

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Today's Range

Now: $199.75

$198.68

$204.82

50 Day Range

MA: $212.54

$199.44

$222.13

2 Week Range

Now: $199.75

$174.20

$234.09

Volume

333,099 shs

Average Volume

732,207 shs

Market Capitalization

$16.80 billion

P/E Ratio

42.77

Dividend Yield

1.38%

Beta

1.01